SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: mick, DewDiligence, wshaw14
Search This Board: 
Last Post: 2/24/2017 8:45:57 PM - Followers: 109 - Board type: Free - Posts Today: 12


GILD Investor Relations

http://www.otcmarkets.com/stock/GILD/quote
http://www.otcmarkets.com/stock/GILD/profile
Contact Info
  • 333 Lakeside Drive
    Foster City, CA 94404
GILD Security Details
Share Structure
  Market Value1 $94,343,029,244 a/o Dec 30, 2016
  Authorized Shares Not Available
  Outstanding Shares 1,317,456,071 a/o Oct 31, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.001
Transfer Agent(s)
BNYMellon Shareowner Services
Shareholders
Shareholders of Record 363 a/o Feb 24, 2016
Corporate Actions
  Ex. Date Record Date Pay Date
Dividend (0.47) Dec 13, 2016 Dec 15, 2016 Dec 29, 2016
Dividend (0.47) Sep 14, 2016 Sep 16, 2016 Sep 29, 2016
Dividend (0.47) Jun 14, 2016 Jun 16, 2016 Jun 29, 2016
 
Dividends are not adjusted for stock splits
Security Notes
  • Capital Change=shs increased by 2 for 1 split. Ex-date=03/08/2002. Rec date=02/14/2002. Pay date=03/07/2002.
    Latest Addt'l Issue=2-96 4,000,000 shs at $37.75 by Robertson, Stephens & Co. et al.
    New Issue=1-92 5,000,000 shs at $15 by Robertson, Stephens & Co., et al.
    Capital Change=shs increased by 2 for 1 split. Ex-date=02/22/2001. Rec date=02/02/2001. Pay date=02/21/2001.
    Capital Change=shs increased by 2 for 1 split. Ex-date=09/07/2004. Rec date=08/12/2004. Pay date=09/03/2004.
    Capital Change=shs increased by 2 for 1 split Ex-date=06/25/2007. Rec date=05/24/2007. Pay date=06/22/2007.
    Capital Change=shs increased by 2 for 1 split. Ex-date=01/28/2013. Rec date=01/07/2013. Pay date=01/25/2013.

    http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=d
    http://finviz.com/ ;



  •  
***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.









     
 
Short Selling Data
Short Interest 19,440,457 (-7.51%)
Nov 30, 2010
Significant Failures to Deliver No


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD
Current Price
Volume:
Bid Ask Day's Range
SureTrader
GILD News: Ontario Becomes First Province To List EPCLUSA™ On Public Drug Plan To Treat All Six Genotypes Of Chronic Hepatitis C Infec... 02/22/2017 11:36:00 AM
GILD News: Current Report Filing (8-k) 02/21/2017 04:55:58 PM
GILD News: Gilead Receives Approval in Canada for ODEFSEY™ for the Treatment of HIV-1 Infection 02/16/2017 11:30:00 AM
GILD News: Gilead reçoit l'approbation au Canada d'ODEFSEY(MC) pour le traitement de l'infection par le VIH-1 02/16/2017 11:30:00 AM
GILD News: Gilead Announces 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve Adults 02/14/2017 07:00:00 PM
PostSubject
#2444  Sticky Note After tough year, 9 questions for Gilead mick 01/03/17 02:27:26 PM
#2436  Sticky Note More on same topic—(MRK-GILD patent case): #msg-127266273. DewDiligence 12/17/16 10:47:08 AM
#2542   Same as yours, opposite of chmcnfunds, see #2505- #2512 north40000 02/24/17 08:45:57 PM
#2541   What was your position? TIA. LongRun8 02/24/17 08:28:01 PM
#2540   Could be, and I would think that there BlackDoggie 02/24/17 02:22:21 PM
#2539   I think cydy would be a nice fit 123boom 02/24/17 02:19:45 PM
#2538   GILD's HIV franchise is pretty much set in DewDiligence 02/24/17 02:15:10 PM
#2537   Charlie Sheen has been taking pro140 with out 123boom 02/24/17 02:07:41 PM
#2536   BTD (if PRO 140 gets it) is no DewDiligence 02/24/17 01:59:58 PM
#2535   HIV patients are suited for a CCR5 agent DewDiligence 02/24/17 01:56:38 PM
#2534   Mr. Dew I encourage you to do some 123boom 02/24/17 01:51:55 PM
#2533   Interesting - thanks for the response and the BlackDoggie 02/24/17 01:30:04 PM
#2532   Doubtful, IMO. CYDY’s PRO 140, at best, addresses DewDiligence 02/24/17 01:07:06 PM
#2531   interesting Fibanotch 02/24/17 08:53:23 AM
#2530   With all of the acquisition talk on this BlackDoggie 02/23/17 06:00:39 PM
#2529   Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA Access To Be trendmkr 02/23/17 02:12:19 PM
#2528   Bingo, a use for the voucher: chmcnfunds 02/23/17 07:35:17 AM
#2527   No problem. Cheers. LongRun8 02/22/17 10:17:42 PM
#2526   3 Things Gilead Sciences' CEO Just Said That wshaw14 02/22/17 06:15:11 PM
#2525   Dew agreed with my position via PM yesterday. north40000 02/22/17 04:55:33 PM
#2524   Ontario Becomes First Province To List EPCLUSA™ On wshaw14 02/22/17 01:13:37 PM
#2523   If this breaks through $70, will quickly run jones99 02/22/17 04:26:57 AM
#2522   Thanks for the link. Looks like you are correct. wshaw14 02/21/17 08:46:27 PM
#2521   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209531Orig1s000Approv.pdf LongRun8 02/21/17 07:40:32 PM
#2520   Link please " without regard to the indication wshaw14 02/21/17 05:47:09 PM
#2519   GILD -- Priority review voucher I wouldn't read too LongRun8 02/21/17 05:03:08 PM
#2518   That was my first reaction upon reading of wshaw14 02/21/17 04:43:11 PM
#2517   From what I read GILD now has 2 chmcnfunds 02/21/17 04:28:30 PM
#2516   I also increased my position today by 40%. wshaw14 02/21/17 02:25:36 PM
#2515   Good Wshaw...No conflict. shub 02/21/17 02:07:49 PM
#2514  Restored What indication is GILD pursuing, or contemplating pursuing, north40000 02/21/17 01:19:18 PM
#2512   I believe it is a pediatric voucher which chmcnfunds 02/21/17 12:52:43 PM
#2511   Thanks, but still no reference to any age north40000 02/21/17 12:18:06 PM
#2510   Gilead Gets The Best Of Sarepta In $125M wshaw14 02/21/17 12:17:02 PM
#2509   Another take: chmcnfunds 02/21/17 12:08:59 PM
#2508   Thanks for the information. I still see no north40000 02/21/17 12:07:31 PM
#2507   I believe they were referring to this: chmcnfunds 02/21/17 11:50:20 AM
#2506   "Gilead (Nasdaq: GILD) may now use the voucher north40000 02/21/17 11:33:06 AM
#2505   Sarepta sells FDA review voucher for $125M, but chmcnfunds 02/21/17 10:51:39 AM
#2504   I am not disputing the $100. I am wshaw14 02/20/17 06:29:07 PM
#2503   I fully expect it to return to $100+ shub 02/19/17 03:22:32 PM
#2502   LOl. I was only saying that it should wshaw14 02/18/17 10:35:21 AM
#2501   Respectfully, that sort of analysis seems a lot shub 02/17/17 03:54:46 PM
#2500   This has about $18.00 to run before it wshaw14 02/17/17 03:51:52 PM
#2499   We concur; shub 02/17/17 03:34:56 PM
#2498   They are still well below value. Patience is wshaw14 02/17/17 03:16:17 PM
#2497   Owning HIV treatment like they do, as well shub 02/17/17 02:43:01 PM
#2496   Gap filled and MACD cross-over today. Waiting for chmcnfunds 02/17/17 09:38:47 AM
#2495   Thanks for the link. You beat me to wshaw14 02/16/17 12:06:13 PM
#2493   Gilead Receives Approval In Canada For ODEFSEY(TM) For chmcnfunds 02/16/17 11:45:33 AM
#2492   I have only been holding since the 9th. wshaw14 02/15/17 04:23:34 PM
#2491   So far so good. Good news today and chmcnfunds 02/15/17 04:13:04 PM
PostSubject